Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
70,335,073
-
Share change
-
+2,789,426
-
Total reported value
-
$893,236,744
-
Put/Call ratio
-
824%
-
Price per share
-
$12.70
-
Number of holders
-
129
-
Value change
-
+$42,360,526
-
Number of buys
-
72
-
Number of sells
-
61
Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) as of Q1 2018
As of 31 Mar 2018,
ALDER BIOPHARMACEUTICALS INC - COM (ALDR) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,335,073 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Foresite Capital Management III, LLC, Partner Fund Management, L.P., BB BIOTECH AG, AMERIPRISE FINANCIAL INC, and FMR LLC.
This page lists
129
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.